glp-1 drugs pharmaceutical companies news 2025 weight loss are back in the GLP-1 Pipeline Update: November 2025

They are not comparable to any over-the-counter patch on the market

Research published in neuroscience journals has shown that administration of exenatide, liraglutide, and semaglutide decreases alcohol consumption in alcohol-preferring rats and mice, with effects observed across various experimental paradigms including two-bottle choice tests and operant self-administration models

Due to the increasing popularity of GLP-1RAs in patients with obesity, it seems crucial to recognise the peri-operative management in this group of patients

doi: 10.1016/j.bone.2013.07.003

10.3389/fphar.2022.855779 [DOI] [PMC free article] [PubMed] [Google Scholar] Ishikawa M., Takaseki S., Yoshitomi T., Covey D

Additionally, Mounjaro slows gastric emptying , which prolongs the feeling of fullness after meals, and suppresses glucagon secretion , a hormone that raises blood glucose